158 related articles for article (PubMed ID: 23165696)
1. Randomized, double-blind, placebo-controlled, phase II trial of gabapentin enacarbil for migraine prophylaxis.
Silberstein S; Goode-Sellers S; Twomey C; Saiers J; Ascher J
Cephalalgia; 2013 Jan; 33(2):101-11. PubMed ID: 23165696
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome.
Lal R; Ellenbogen A; Chen D; Zomorodi K; Atluri H; Luo W; Tovera J; Hurt J; Bonzo D; Lassauzet ML; Vu A; Cundy KC
Clin Neuropharmacol; 2012; 35(4):165-73. PubMed ID: 22664749
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of gabapentin enacarbil in subjects with neuropathic pain associated with postherpetic neuralgia (PXN110748).
Zhang L; Rainka M; Freeman R; Harden RN; Bell CF; Chen C; Graff O; Harding K; Hunter S; Kavanagh S; Laurijssens B; Schwartzbach C; Warren S; McClung C
J Pain; 2013 Jun; 14(6):590-603. PubMed ID: 23602345
[TBL] [Abstract][Full Text] [Related]
4. Cardiac repolarization with Gabapentin enacarbil in a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults.
Davy M; Upward J; Arumugham T; Twomey C; Chen C; Stier B
Clin Ther; 2013 Dec; 35(12):1964-74. PubMed ID: 24290737
[TBL] [Abstract][Full Text] [Related]
5. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
6. Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial.
Walters AS; Ondo WG; Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
Clin Neuropharmacol; 2009; 32(6):311-20. PubMed ID: 19667976
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin.
Backonja MM; Canafax DM; Cundy KC
Pain Med; 2011 Jul; 12(7):1098-108. PubMed ID: 21627766
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
[TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled trial of gabapentin enacarbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy.
Rauck R; Makumi CW; Schwartz S; Graff O; Meno-Tetang G; Bell CF; Kavanagh ST; McClung CL
Pain Pract; 2013 Jul; 13(6):485-96. PubMed ID: 23186035
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.
Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC
Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136
[TBL] [Abstract][Full Text] [Related]
12. Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbil.
Bogan RK; Lee DO; Buchfuhrer MJ; Jaros MJ; Kim R; Shang G
Ann Med; 2015 May; 47(3):269-77. PubMed ID: 25874578
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
14. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
[TBL] [Abstract][Full Text] [Related]
15. Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study.
Silberstein S; Saper J; Berenson F; Somogyi M; McCague K; D'Souza J
Neurology; 2008 Feb; 70(7):548-55. PubMed ID: 18268247
[TBL] [Abstract][Full Text] [Related]
16. Gabapentin enacarbil and morphine administered in combination versus alone: a double-blind, randomized, pharmacokinetic, and tolerability comparison.
Chen C; Upward J; Arumugham T; Stier B; Davy M
Clin Ther; 2015 Feb; 37(2):349-57. PubMed ID: 25467190
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of gabapentin enacarbil on cardiac repolarization: a randomized, double-blind, placebo- and active-controlled, crossover thorough QT/QTc study in healthy adults.
Chen D; Lal R; Zomorodi K; Atluri H; Ho J; Luo W; Tovera J; Bonzo D; Cundy K
Clin Ther; 2012 Feb; 34(2):351-362.e3. PubMed ID: 22325733
[TBL] [Abstract][Full Text] [Related]
18. A phase 2a, randomized, crossover trial of gabapentin enacarbil for the treatment of postherpetic neuralgia in gabapentin inadequate responders.
Harden RN; Freeman R; Rainka M; Zhang L; Bell C; Berges A; Chen C; Graff O; Harding K; Hunter S; Kavanagh S; Schwartzbach C; Warren S; McClung C
Pain Med; 2013 Dec; 14(12):1918-32. PubMed ID: 24102928
[TBL] [Abstract][Full Text] [Related]
19. Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults.
Linde M; Mulleners WM; Chronicle EP; McCrory DC
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD010609. PubMed ID: 23797675
[TBL] [Abstract][Full Text] [Related]
20. Randomized polysomnography study of gabapentin enacarbil in subjects with restless legs syndrome.
Winkelman JW; Bogan RK; Schmidt MH; Hudson JD; DeRossett SE; Hill-Zabala CE
Mov Disord; 2011 Sep; 26(11):2065-72. PubMed ID: 21611981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
